The Gross Margin of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS) is 44.27%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 44.27% |
| 2023-12-31 | 49.93% |
| 2022-12-31 | 52.90% |
| 2021-12-31 | 60.13% |
| 2020-12-31 | 59.16% |
| 2019-12-31 | 62.88% |
| 2018-12-31 | 60.77% |
| 2017-12-31 | 60.09% |
| 2016-12-31 | 66.13% |
| 2015-12-31 | 74.03% |